General Information
Version
CAT 1267 - atorvastatin calcium
Revision date
2025-12-12
Product name
atorvastatin calcium
Substance name
Atorvastatin Calcium
CAS No.
344423-98-9
1.2.1 Relevant identified uses
Laboratory use
supplier name
British Pharmacopoeia Commission
Emergency telephone
+44 (0)20 3080 6561
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H361fd, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Atorvastatin Calcium
Signal word
Warning
Hazard statements
H315 - Causes skin irritation. H361fd - Suspected of damaging fertility. Suspected of damaging the unborn child. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P201 - Obtain special instructions before use P260 - Do not breathe dust, fume, gas, mist, vapors and spray P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves, protective clothing, eye protection and face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P321 - Specific treatment (see supplemental first aid instructions on this label)
2.3 Other hazards
No information available.
PBT Substances
& vPvB This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin irritation Category 2 - (H315) Reproductive toxicity Category 2 - (H361fd) Specific target organ toxicity (repeated exposure) Category 2 - (H373)
